Scarica l'app Stockscreener
1.64
10.87%
-0.20
Pre-mercato:
1.63
-0.01
-0.61%
Scisparc Ltd Borsa (SPRC) Ultime notizie
SciSparc Ltd. (SPRC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
SciSparc Stock Soars Pre-Market After Snapping Up Patents For Next-Gen Endoscopy Tech - MSN
SciSparc Shares Experience Pre-Bell Dip Following Quiet Session - timothysykes.com
SciSparc (SPRC) Stock on December 5, 2025: Price Action, Quantum Data Deal, GERD Device Pivot and 2030 Forecast - ts2.tech
Will SciSparc Ltd. stock outperform growth indexesJuly 2025 Final Week & Growth-Oriented Investment Plans - Newser
NeuroThera to acquire 55% stake in quantum computing bio data company - MSN
SciSparc Shares Slide After Revealing Plans to Acquire MUSE Endoscopic System IP - MSN
SciSparc’s NeuroThera Labs Eyes Quantum Leap with New Acquisition - TipRanks
SciSparc Ltd. Announces NeuroThera Labs' Planned Acquisition of Quantum Computing Bio Data Company - Quiver Quantitative
SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to Acquire Majority Stake in a Quantum Algorithm Bio Data Analysis Company - The Manila Times
SciSparc (Nasdaq: SPRC) NeuroThera signs term sheet for 55% quantum data stake - Stock Titan
SciSparc plans to enter GERD device market with IP portfolio acquisition - MSN
symbol__ Stock Quote Price and Forecast - CNN
SciSparc (SPRC) Stock Analysis Report | Financials & Insights - Benzinga
SciSparc stock tumbles after announcing MUSE system acquisition plans By Investing.com - Investing.com UK
SciSparc Ltd. (SPRC) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
SciSparc stock tumbles after announcing MUSE system acquisition plans - Investing.com
SciSparc to acquire MUSE endoscopic system patents from Xylo By Investing.com - Investing.com Nigeria
SciSparc to acquire MUSE endoscopic system patents from Xylo - Investing.com
SciSparc Plans on Entering the Multi-Billion-Dollar GERD Device Market with Acquisition of an Approved IP Portfolio - The Manila Times
Scisparc plans on entering the multi-billion-dollar GERD device market with acquisition of an approved IP portfolio - marketscreener.com
SciSparc Ltd. Signs Agreement to Acquire Patents and Intellectual Property for Innovative MUSE™ Endoscopic System from Xylo Technologies Ltd. - Quiver Quantitative
Scisparc Plans On Entering The Multi-Billion-Dollar Gerd Device Market With Acquisition Of An Approved IP Portfolio - TradingView
SciSparc acquires Xylo Technologies' innovative endoscopic portfolio - Indian Pharma Post
SciSparc Ltd. (SPRC) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
SciSparc Ltd. Announces $2.2 Million Securities Offering - The Globe and Mail
Form 424B5 SciSparc Ltd. - StreetInsider
Is SciSparc Ltd a good long term investmentStock Buyback Announcements & Free Tap Rapid Wealth - earlytimes.in
What analysts say about SciSparc Ltd stockMid Cap Growth Trends & Minimal Investment Trading Tips - earlytimes.in
SciSparc to acquire treasury of patents for medical endoscopy systems - MSN
SciSparc Shares Surge After Company Moves to Acquire GERD Treatment Technology - MSN
SciSparc’s Stock Slip: Investment Opportunity? - timothysykes.com
SciSparc Ltd. to Acquire Xylo’s Patents for Endoscopic Systems - TipRanks
[6-K] SciSparc Ltd. Current Report (Foreign Issuer) | SPRC SEC FilingForm 6-K - Stock Titan
SciSparc’s Patent Surge: Buy or Hold? - StocksToTrade
SciSparc Ltd. (SPRC) Stock: Jumps as Company Expands into High-Growth GERD Device Market - parameter.io
Why SciSparc Stock Is Gaining TodaySciSparc (NASDAQ:SPRC) - Benzinga
SciSparc to acquire endoscopic system patents from Xylo Technologies By Investing.com - Investing.com Nigeria
SciSparc Stocks Surge: A Strategic Leap Forward? - timothysykes.com
SciSparc stock soars after acquiring GERD treatment technology By Investing.com - Investing.com Nigeria
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):